miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1

Physiological Genomics

Volumn 45, Issue 12, 2013, Pages 493-498

  Evangelista, Alicia M ^a   Deschamps, Anne M ^a   Liu, Delong ^a   Raghavachari, Nalini ^a   Murphy, Elizabeth ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cardiac; ets 1; miR 222; Nitric oxide synthase; Sexual dimorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; LUCIFERASE; MICRORNA; MICRORNA 1; MICRORNA 106B; MICRORNA 144; MICRORNA 205; MICRORNA 222; MICRORNA 29B; MICRORNA 34B 3P; MICRORNA 720; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; ERYTHROBLASTOSIS; FEMALE; GENE CONTROL; HEART MUSCLE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; WESTERN BLOTTING;

CARDIAC; ETS-1; MIR-222; NITRIC OXIDE SYNTHASE; SEXUAL DIMORPHISM;

ANIMALS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCARDIUM; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE III; PROTO-ONCOGENE PROTEIN C-ETS-1; SEX CHARACTERISTICS;

MUS;

EID: 84879134487     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00008.2013     Document Type: Article

References (41)

1. Bernardo BC, Gao XM, Winbanks CE, Boey EJ, Tham YK, Kiriazis H, Gregorevic P, Obad S, Kauppinen S, Du XJ, Lin RC, McMullen JR. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci USA 109: 17615-17620, 2012.
2. Bidoggia H, Maciel JP, Capalozza N, Mosca S, Blaksley EJ, Valverde E, Bertran G, Arini P, Biagetti MO, Quinteiro RA. Sex-dependent electrocardiographic pattern of cardiac repolarization. Am Heart J 140: 430-436, 2000.
3. Bostjancic E, Zidar N, Stajer D, Glavac D. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115: 163-169, 2010.
4. Bostjancic E, Zidar N, Stajner D, Glavac D. MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction. Folia Biol (Praha) 56: 27-31, 2010.
5. Brede M, Roell W, Ritter O, Wiesmann F, Jahns R, Haase A, Fleischmann BK, Hein L. Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice. Hypertension 42: 1177-1182, 2003.
6. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, Hannon GJ, Stebbing J. The estrogen receptor-a-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA 106: 15732-15737, 2009.
7. Chan Y, Fish JE, D'Abreo C, Lin S, Robb GB, Teichert AM, Karantzoulis-Fegaras F, Keightley A, Steer BM Marsden PA. The cell-specific expression of endothelial nitric-oxide synthase. J Biol Chem 279: 35087-35100, 2004.
8. Cross HR, Murphy E, Koch WJ, Steenbergen C. Male and female mice overexpressing the |32-adrenergic receptor exhibit differences in ischemia/ reperfusion injury: role of nitric oxide. Cardiovasc Res 53: 662-671, 2002.
9. 2+ loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 283: H481-H489, 2002.
10. 2+ channel modulation. Eur J Pharmacol 586: 288-292, 2008.
11. de Simone G, Devereux RB, Daniels SR, Meyer RA. Gender differences in left ventricular growth. Hypertension 26: 979-983, 1995.
12. Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, Brizzi MF. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 30: 1562-1568, 2010.
13. Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM. MicroRNA cluster 221-222 and estrogen receptor a interactions in breast cancer. J Natl Cancer Inst 102: 706-721, 2010.
14. Dickinson BA, Semus HM, Montgomery RL, Stack C, Latimer PA, Lewton SM, Lynch JM, Hullinger TG, Seto AG, van Rooij E. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. Eur J Heart Fail [Epub ahead of print].
15. du Toit EF, Genade S, Carlini S, Moolman JA, Brunner F, Lochner A. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. Eur J Pharmacol 556: 115-120, 2007.
16. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucl Acids Res 30: 207-210, 2002.
17. El-Armouche A, Schwoerer AP, Neuber C, Emmons J, Biermann D, Christalla T, Grundhoff A, Eschenhagen T, Zimmermann WH, Eh-mke H. Common microRNA signatures in cardiac hypertrophic and atrophic remodeling induced by changes in hemodynamic load. PLoS One 5: e14263, 2010.
18. Elrod JW, Greer JJ, Bryan NS, Langston W, Szot JF, Gebregzlabher H, Janssens S, Feelisch M, Lefer DJ. Cardiomyocyte-specific overex-pression of NO synthase-3 protects against myocardial ischemia-reperfu-sion injury. Arterioscler Thromb Vasc Biol 26: 1517-1523, 2006.
19. Farrell SR, Ross JL, Howlett SE. Sex differences in mechanisms of cardiac excitation-contraction coupling in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 299: H36-H45, 2010.
20. Gonzalez DR, Beigi F, Treuer AV, Hare JM. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Natl Acad Sci USA 104: 20612-20617, 2007.
21. Gyurko R, Kuhlencordt P, Fishman MC, Huang PL. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol Heart Circ Physiol 278: H971-H981, 2000.
22. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT. Altered microRNA expression in human heart disease. Physiol Genomics 31: 367-373, 2007.
23. Karantzoulis-Fegaras F, Antoniou H, Lai SLM, Kulkarni G, D'Abreo C, Wong GKT, Miller TL, Chan Y, Atkins J, Wang Y, Marsden PA. Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem 274: 3076-3093, 1999.
24. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Förstermann U. Estrogens increase transcription of the human endothelial NO synthase gene. Hypertension 31: 582-588, 1998.
25. Kuch B, Hense HW, Sinnreich R, Kark JD, von Eckardstein A, Sapoznikov D, Bolte HD. Determinants of short-period heart rate variability in the general population. Cardiology 95: 131-138, 2001.
26. Massion PB, Dessy C, Desjardins F, Pelat M, Havaux X, Belge C, Moulin P, Guiot Y, Feron O, Janssens S, Balligand JL. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates fj-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 110: 2666-2672, 2004.
27. Mattia G, Errico MC, Felicetti F, Petrini M, Bottero L, Tomasello L, Romania P, Boe A, Segnalini P, Di Virgilio A, Colombo MP, Carè A. Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma. Pigm Cell Melanoma Res 24: 953-965, 2011.
28. Murphy E, Steenbergen C. Cardioprotection in females: a role for nitric oxide and altered gene expression. Heart Fail Rev 12: 293-300, 2007.
29. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, Vetter H, Grohé C. 17fj-Estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res 43: 666-674, 1999.
30. Rosenkranz-Weiss P, Tomek RJ, Mathew J, Eghbali M. Gender-specific differences in expression mRNAs for functional and structural proteins in rat ventricular myocardium. J Mol Cell Cardiol 26: 261-270, 1994.
31. Sterin-Borda L, Bernabeo G, Ganzinelli S, Joensen L, Borda E. Role of nitric oxide/cyclic GMP and cyclic AMP in |33 adrenoceptor-chronotropic response. J Mol Cell Cardiol 40: 580-588, 2006.
32. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 100: 1164-1173, 2007.
33. Sun J, Kohr MJ, Nguyen T, Aponte AM, Connelly PS, Esfahani SG, Gucek M, Daniels MP, Steenbergen C, Murphy E. Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins. Antioxid Redox Signal 16: 45-56, 2012.
34. Sun J, Morgan M Shen RF, Steenbergen C, Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res 101: 1155-1163, 2007.
35. 2+ channel a1 subunit and reduced ischemia/reperfusion injury. Circ Res 98: 403-411, 2006.
36. Talukder MAH, Yang F, Shimokawa H, Zweier JL. eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex. Am J Physiol Heart Circ Physiol 299: H437-H445, 2010.
37. Thomas NM, Jasmin JF, Lisanti MP, Iacobas DA. Sex differences in expression and subcellular localization of heart rhythm determinant proteins. Biochem Biophys Res Commun 406: 117-122, 2011.
38. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105: 13027-13032, 2008.
39. Varghese P, Harrison RW, Lofthouse RA, Georgakopoulos D, Berkowitz DE, Hare JM. fj3-Adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility. J Clin Invest 106: 697-703, 2000.
40. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ. MicroRNA-221/222 negatively regulates estrogen receptora and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283: 31079-31086, 2008.
41. Zhao J, Imbrie GA, Baur WE, Iyer LK, Aronovitz MJ, Kershaw TB, Haselmann GM, Lu Q, Karas RH. Estrogen receptor-mediated regulation of microRNA inhibits proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 33: 257-265, 2013.